Amgen 20. Apr. 2026 Zurcher Kantonalbank Zurich Cantonalbank Buys 55,333 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen 20. Apr. 2026 Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
Pfizer 20. Apr. 2026 Exclusive | Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source - South China Morning Post
Amgen 16. Apr. 2026 Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com
FierceBiotech 14. Apr. 2026 Boehringer, Amgen discard early immunology candidates over lack of clinical potential
BioPharma Dive 6. Apr. 2026 Under-the-skin Tepezza comparable to infused version in key study, Amgen says
Endpoints News 6. Apr. 2026 Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
FierceBiotech 30. März 2026 Viridian’s other rival to Amgen’s Tepezza scores phase 3 win, but investors need convincing
BioPharma Dive 4. Feb. 2026 Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
FierceBiotech 4. Feb. 2026 Amgen advances toward lupus redemption while gastric cancer candidate struggles